Complementary or alternative medicine as possible determinant of decreased persistence to aromatase inhibitor therapy among older women with non-metastatic breast cancer.

Complementary or alternative medicine as possible determinant of decreased persistence to aromatase inhibitor therapy among older women with non-metastatic breast cancer.

<h4>Purpose</h4>Aromatase inhibitor therapy (AI) significantly improves survival in breast cancer patients. Little is known about adherence and persistence to aromatase inhibitors and about the causes of treatment discontinuation among older women.<h4>Methods</h4>We constitut...

Full description

Bibliographic Details
Main Authors: Laetitia Huiart, Anne-Deborah Bouhnik, Dominique Rey, Frédérique Rousseau, Frédérique Retornaz, Mégane Meresse, Marc Karim Bendiane, Patrice Viens, Roch Giorgi
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS ONE
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24367488/?tool=EBI

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24367488/?tool=EBI

Similar Items